It’s Time to Buy the Dip in Zosano Pharma Corporation [ZSAN] Stock

Over the past three months, Zosano Pharma Corporation [ZSAN] ended the trading day at $0.61 and exhibited a change of -2.22% with a 24 hour trading and reached upto the volume of 5.71M compared to its recorded trading volume of 1.01 million. ZSAN generated a 1 year amount change with -63.60%. Though for Principal markets a year is counted as a long time period. By having a look at the most recent performance of this stock, in the last week its amount moved by -3.79% with an amount shift of 74.10% over the last month.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


On 7, December 2020, The Gross Law Firm Announces Class Actions on Behalf of Shareholders of TRQ, ZSAN and LRN. According to news published on Yahoo Finance, NEW YORK, NY / ACCESSWIRE / December 7, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Analyst Birdseye View:

The most recent analyst activity for Zosano Pharma Corporation [NASDAQ:ZSAN] stock was on March 24, 2017, when it was Initiated with an Overweight rating from Piper Jaffray, which also raised its 12-month price target on the stock to $4. Before that, on April 17, 2019, Maxim Group Recapitulated a Buy rating and elevated its amount target to $8. On August 11, 2016, Ladenburg Thalmann Downgrade a Neutral rating. On November 11, 2015, ROTH Capital Reiterated a Buy rating and decreased its price target from $11 to $7. On September 29, 2015, ROTH Capital Reiterated a Buy rating and decreased its price target to $11. On February 23, 2015, ROTH Capital Initiated a Buy rating and boosted its amount on this stock to $20.

In the past 52 weeks of trading, this stock has oscillated between a low of $0.33 and a peak of $1.96. Right now, according to Wall Street analyst the average 12-month amount target is $1.83. At the most recent market close, shares of Zosano Pharma Corporation [NASDAQ:ZSAN] were valued at $0.61.


If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 65.40 and the whole liability to whole assets at 47.13. It shows enduring liability to the whole principal at 44.36 and enduring liability to assets at 0.32 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 0.6084 points at 1st support level, the second support level is making up to 0.5944. But as of 1st resistance point, this stock is sitting at 0.6381 and at 0.6538 for 2nd resistance point.

Zosano Pharma Corporation [ZSAN] reported its earnings at -$0.11 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.1/share signifying the difference of -0.01 and -10.00% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were -$0.14 calling estimates for -$0.14/share with the difference of 0 depicting the surprise of 0.00%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for Zosano Pharma Corporation [NASDAQ:ZSAN] is 3.40. Likewise, the Quick ratio is also the same, showing Cash ratio at 0.39. Now if looking for a valuation of this stock’s amount to book ratio is 3.80.